Delivery Order SPE2DB22D2218-SPE2DB24FR2NX
Award Date
5/10/24
Potential Completion Date
6/3/24
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ingrezza 40 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a firm fixed price of $11,028.36. The award has an ultimate completion date of December 24, 2024. The contract is a delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award is for the delivery of Ingrezza 40 mg capsules to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The contract, valued at $3,553.31, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and supplier to the federal government. The contract is a Firm Fixed Price Delivery Order, with a completion date of June 28, 2024. It is not associated with a set-aside designation. Amerisourcebergen...
This federal contract award is for the delivery of Ingrezza 40 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $7,106.64 and a completion date of November 1, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $3,553.31, covers the delivery of Ingrezza 40 mg capsules to the U.S. government. The contract, awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with a completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain capabilities to fulfill government...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Ingrezza 80 mg capsules. The contract, valued at $3,893.15, is a firm fixed-price delivery order that has an ultimate completion date of October 2, 2024. The contract is not designated as a set-aside. AmerisourceBergen, through its Corporate Office division, has been a significant supplier of pharmaceutical and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,119.55 firm fixed-price delivery order is for the supply of Ingrezza 40 mg capsules with a completion date of June 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ingrezza 40 mg capsules in 30-count packages. The award, valued at $3,553.31, was made by the Defense Logistics Agency (DLA) on May 26, 2024, with a completion date of June 17, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,676.12 firm fixed-price delivery order is for the drug Ingrezza 40 mg capsules. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $7,786.30 firm-fixed-price delivery order is for the supply of 4,564,676,900 units of the drug Ingrezza (80 mg capsules, 30-count) to support the Department of Defense (DoD) and other government agencies. Amerisourcebergen is a large pharmaceutical distribution company that holds several Indefinite Delivery Contracts...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,553.31 firm fixed-price delivery order is for the provision of Ingrezza 40 mg capsules, a medication used to treat a neurological disorder. This award is a part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...